RASHIDA HASSANALI: Open Payments
NPI 1700245313 · CHERRY HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,254 in 112 payments from 14 companies in 2025. Trend: 2023 $570 · 2024 $1,142 · 2025 $3,254
Food & beverage: $1,924Speaker / faculty: $1,330
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 29 | $1,804 |
| ABBVIE INC. | 32 | $395 |
| Journey Medical Corporation | 7 | $206 |
| Novartis Pharmaceuticals Corporation | 11 | $184 |
| Amgen Inc. | 4 | $183 |
| Incyte Corporation | 11 | $161 |
| Organon LLC | 7 | $141 |
| Lilly USA, LLC | 4 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
Products named: SKYRIZI, NEMLUVIO, OTEZLA, AKLIEF, OPZELURA, RINVOQ, Rhapsido, VTAMA.
Industry payments across NJ — which companies pay providers there.
